FDA Publishes Framework for Digital Health Technologies in Clinical Trials | Foley & Lardner LLP

On March 23, the U.S. Food and Drug Administration (FDA) published a framework to guide regulatory decision-making on the use of digital health technologies (DHT) in clinical drug...

Related Keywords

,Radiological Health ,Drug Administration ,Foley Lardner ,Prescription Drug User Fee Act ,Biological Evaluation ,Drug Evaluation ,Decentralized Clinical Trials ,Biological Products ,Regulatory Considerations ,Prescription Drug Use Related ,